Article Sidebar
Published:
Mar 24, 2026Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Impact of educational intervention on the knowledge, attitudes, and practices of pharmacists towards drug interactions among cancer patients
Abstract
Purpose: To assess pharmacists' knowledge, attitude, and practice (KAP) regarding potential drug-drug interactions (PDDIs) among cancer patients.
Methods: A quasi-experimental design with a control group was conducted from May to September 2025. Forty-four pharmacists from two oncology wards, including Babylon Oncology Centre and Al Imam al-Sadeq Hospital in Babylon governorate, Iraq, were selected. The 44 participants were divided equally into 2 groups: intervention group and control group. A validated questionnaire was used to assess KAP regarding drug interactions in oncology wards before and 4 weeks after intervention. Only intervention group received the educational intervention, which included a scientific lecture, booklets, and brochures. While control group didn’t receive any intervention.
Results: The pre-intervention KAP scores were 54.16, 66.47, and 69.77 % for knowledge, attitudes, and practices, respectively, in intervention group. Post-intervention scores of KAP of intervention group were 84.28, 90.11, and 80.07 %, respectively, which show a significant increase in all KAP domains (p < 0.05) in intervention group. No significant change (p > 0.05) was observed in control group across pre-post study phase (40.909 ± 27.053 vs 44.691 ± 23.611), (62.727 ± 10.261 vs 62.95 ± 9.214), and (67.575 ± 14.913 vs 66.515 ± 13.322) for KAP, respectively, but significant change was found when compared with intervention group (p < 0.05).
Conclusion: There is suboptimal KAP regarding drug interactions among the pharmacists assessed, and educational intervention significantly enhanced their KAP regarding drug interactions in oncology settings. Structured educational programs on PDDIs, especially in oncology settings, aim to ensure cancer patients' safety and minimize unwanted drug-related issues, which is therefore advocated.
